drugset / Trial / NCT06955533
Single Dose Versus Double Dose Tamsulosin 0.4 and Solifenacin 5 in Management of Stent Related Symptoms
RandomizedParallel-groupTriple-blindTreatment
Summary
This study was a randomized clinical trial conducted on 64 Egyptian patients from the outpatient clinic at Ain Shams University Hospital over a six-month period from 3/2024 to 9/2024.The study population was randomized into 2 groups. Group A included 32 patients with stent related symptoms receiving double doses of tamsulosin (Tamsulin® 0.4 mg 2 capsules taken together per day) and Solifenacin 10mg (Sofenacin® 10mg tab taken once daily).Group B included 32 patients with stent related symptoms receiving a standard dose of tamsulosin (0.4 mg once daily) and solifenacin (5 mg once daily).
Timeline
- Start
- 2024-04-01
- Primary completion
- 2024-08-01
- Completion
- 2024-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Solifenacin | Small molecule | 5 mg | — |
| Comparator | Solifenacin | Small molecule | 10 mg | — |
| Comparator | Tamsulosin | Other / unclassified | 0.4 mg | — |
| Comparator | Tamsulosin | Other / unclassified | 0.8 mg | — |
Indications
No indication recorded.